54 Followers on Owler

Asklepion Pharmaceuticals

CEO Avatar

CEO

Gary Pasternack

CEO Approval Rating

70/100

Founded:

2006

Status:

PrivateIndependent Company

Est. Annual Revenue
$10M
Agree?
Est. Employees
49
Agree?

Asklepion Pharmaceuticals Acquisitions

No recent acquisitions found related to Asklepion Pharmaceuticals

Asklepion Pharmaceuticals Funding History

No recent funding data found related to Asklepion Pharmaceuticals

Asklepion Pharmaceuticals Investments

No recent investments found related to Asklepion Pharmaceuticals

Asklepion Pharmaceuticals News

December 8, 2017PharmiWeb

Asklepion Pharmaceuticals Presents Phase 1b/2a Clinical Trial Data for IV-Citrulline at the Pediatric Cardiac Intensive Care Society 13th Annual International Meeting

Asklepion Pharmaceuticals Presents Phase 1b/2a Clinical Trial Data for IV-Citrulline at the Pediatric... See more »
March 18, 2015BIOPORTFOLIO

Asklepion secures US OK for Cholbam; wins peds voucher

The luck of the Irish was with Baltimore Marylandbased Asklepion Pharmaceuticals which not only won U... See more »
January 12, 2015BIOPORTFOLIO

Retrophin Announces Acquisition of Exclusive Right to Purchase Cholic Acid from Asklepion Pharmaceuticals

Retrophin Inc. NASDAQRTRX and Asklepion Pharmaceuticals LLC a privately held rare disease pharmaceuti... See more »

Asklepion Pharmaceuticals Press Releases

March 18, 2015PR NEWSWIRE

CHOLBAM (cholic acid) Now Approved In The U.S. For Patients With Bile Acid Synthesis Disorders

BALTIMORE, March 17, 2015 /PRNewswire-USNewswire/ -- Asklepion Pharmaceuticals, LLC. today announced ... See more »
January 12, 2015BUSINESS WIRE

Retrophin Announces Acquisition of Exclusive Right to Purchase Cholic Acid from Asklepion Pharmaceuticals

NEW YORK & BALTIMORE--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) and Asklepion Pharmaceuticals, L... See more »

Social Media

Asklepion Pharmaceuticals Headquarters

729 E Pratt St Ste 360 Suite 360

Baltimore, Maryland21202

1-410-545-0494

Driving Directions »

Trending Companies

Asklepion Pharmaceuticals Summary

ABOUT

Overview

Asklepion Pharmaceuticals was founded in 2006. Asklepion Pharmaceuticals' headquarters is located in Baltimore, Maryland, USA 21202. Asklepion Pharmaceuticals' CEO, Gary Pasternack, currently has an approval rating of 70%. Asklepion Pharmaceuticals ...

CEO

Asklepion Pharmaceuticals's CEO, Gary Pasternack, currently has an approval rating of 70%. Asklepion Pharmaceuticals's primary competitors are

Frequently Asked Questions about Asklepion Pharmaceuticals

  1. When was Asklepion Pharmaceuticals founded?

    Asklepion Pharmaceuticals was founded in 2006
  2. Who is Asklepion Pharmaceuticals's CEO?

    Asklepion Pharmaceuticals's CEO is Gary Pasternack
  3. How much revenue does Asklepion Pharmaceuticals generate?

    Asklepion Pharmaceuticals generates $10M in revenue
  4. How much funding does Asklepion Pharmaceuticals have?

    Asklepion Pharmaceuticals has historically raised $0 in funding
  1. Where is Asklepion Pharmaceuticals's headquarters?

    Asklepion Pharmaceuticals's headquarters is in Baltimore Maryland, USA
  2. How many employees does Asklepion Pharmaceuticals have?

    Asklepion Pharmaceuticals has 49 employees
  3. What sector does Asklepion Pharmaceuticals operate in?

    Asklepion Pharmaceuticals is in Pharmaceuticals